Skip to main content

Table 1 MiR-182-5p expression in LUAD data from RT-qPCR

From: MiR-182-5p and its target HOXA9 in non-small cell lung cancer: a clinical and in-silico exploration with the combination of RT-qPCR, miRNA-seq and miRNA-chip

Clinicopathological parametersnRelevant expression of miR-182-5p (2−ΔCq)
Mean ± SDt/F-valuep-value
TissueLUAD10130.371 ± 5.47514.035< 0.001*
Noncancerous10122.908 ± 3.728
GenderMale5629.923 ± 5.5671.1500.253
Female4528.609 ± 5.879
Age (years)< 604130.642 ± 5.2381.9640.053
≥606028.446 ± 5.899
SmokeNo2631.159 ± 5.4350.6020.550
Yes1830.138 ± 5.671
Tumor size≤3 cm5325.041 ± 4.651−13.541< 0.001*
> 3 cm4834.082 ± 1.343
Vascular invasionNo7028.986 ± 5.839−0.9270.356
Yes3130.130 ± 5.441
TNMI-II4426.730 ± 5.442−4.377< 0.001*
III-IV5731.350 ± 5.114
Lymph node metastasisNo4526.478 ± 5.243−5.023< 0.001*
Yes5631.635 ± 5.036
Pathological gradingI1727.642 ± 5.8630.915b0.404
II6129.753 ± 5.713
III2329.489 ± 5.641
  1. LUAD: lung adenocarcinoma; SD: standard deviation
  2. * The results were statistically significant (P < 0.05)